CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • TGEN Dashboard
  • Financials
  • Filings
  • Transcripts
  • Insider
  • Institutional
  • News
  • Patents
  • 8-K Filing

Tecogen (TGEN) 8-KRegulation FD Disclosure

Filed: 10 Nov 21, 4:08pm
Free signup for more
  • Track your favorite companies
  • Receive email alerts for new filings
  • Personalized dashboard of news and more
  • Access all data and search results
Sign up for free
Search this filing
?
Pre-defined:
Table of contents
    Filing tables
    Export all tables to Excel
    Filing exhibits
    SEC
    • 8-K Current report
    • 99.01 Additional exhibits
    • 99.02 Additional exhibits
    TGEN similar filings
    • 10 Mar 22 Results of Operations and Financial Condition
    • 9 Mar 22 Departure of Directors or Certain Officers
    • 20 Jan 22 Results of Operations and Financial Condition
    • 10 Nov 21 Regulation FD Disclosure
    • 10 Nov 21 Regulation FD Disclosure
    • 12 Oct 21 Regulation FD Disclosure
    • 21 Sep 21 Other Events
    Filing view
    Share this filing


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    __________________________
     
    FORM 8-K

    CURRENT REPORT
    PURSUANT TO SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934

    Date of report: November 10, 2021
    imagea.jpg
    TECOGEN INC. (OTCQX: TGEN)
    (Exact Name of Registrant as Specified in Charter)

    Delaware
    (State or Other Jurisdiction of Incorporation)
    001-36103 04-3536131
    (Commission File Number) (IRS Employer Identification No.)
       
    45 First Avenue  
    Waltham, Massachusetts 02451
    (Address of Principal Executive Offices) (Zip Code)
    (781) 466-6400
    (Registrant's telephone number, including area code)
    _______________________________________________
     
    Securities registered or to be registered pursuant to Section 12(b) of the Act.
    Title of each classTrading SymbolName of exchange on which registered
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o






    Item 2.02. Results of Operations and Financial Condition.

    On November 10, 2021, the registrant issued a press release with earnings commentary and supplemental information for the three and nine months ended September 30, 2021. The press release is furnished as Exhibit 99.01 to this Current Report on Form 8-K.

    The information in this Item 2.02 and Exhibit 99.01 to this Current Report on Form 8-K shall shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.

    Item 7.01. Regulation FD Disclosure.

    On November 11, 2021, the registrant will present the attached slides online in connection with an earnings conference call. The slides are being furnished as Exhibit 99.02 to this Current Report on Form 8-K.

    The information in this Item 7.01 and Exhibit 99.02 to this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.

    Item 9.01. Financial Statements and Exhibits.

    (d) Exhibits

    The following exhibits relating to Items 2.02 and 7.01 shall be deemed to be furnished, and not filed:
    ExhibitDescription
    99.01
    Earnings Release dated November 10, 2021 for the three and nine months ended September 30, 2021
    99.02
    Tecogen Inc.Third Quarter 2021 Earnings Call Presentation dated November 11, 2021

    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
    TECOGEN INC.
    By: /s/ Benjamin Locke
    November 10, 2021Benjamin Locke, Chief Executive Officer

    Finsight
    Resources
    • Knowledgebase
    • Log In
    • Register
    Company
    • About
    • Contact
    • Solutions
    Products
    • Deal Roadshow
    • DealVDR
    • Evercall
    • Finsight.com
    CapEdge
    • Earnings Calendar
    • Earnings Transcripts
    • EDGAR Filing Screener
    • IPO Calendar
    • Compliance
    • Privacy
    • Security
    • Terms
    AngelList LinkedIn